News
1d
GlobalData on MSNClinical trial supply chains in the US navigate pharma tariffs
The 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...
Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors
Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for ...
1d
GlobalData on MSNChina’s clinical trial ecosystem takes centre stage in Suzhou this September
The inaugural Outsourcing in Clinical Trials & Clinical Trial Supply China conference will gather experts to discuss China's ...
AbCellera Biologics (ABCL) marks a milestone, transitioning to clinical-stage biotech with ABCL635 dosing and pipeline expansion.
As clinical trials become more complex, success depends on early collaboration, thoughtful protocol design, and practical ...
Discover Trevi Therapeutics' Q2 2025 progress, featuring groundbreaking CORAL & RIVER trial data, a $204M cash position, and plans for multiple Phase ...
GAAP EPS loss of $1.71 in Q2 2025 slightly missed the consensus estimate by $0.01; revenue remains at zero (GAAP) in Q2 2025, as expected for a clinical-stage biotech. Operating loss (GAAP) widened to ...
Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of RTP-008 ...
Relay Therapeutics beat analyst estimates for both GAAP revenue and earnings per share in Q2 2025. The company reported continued clinical advancement of its lead asset RLY-2608, with new positive ...
Raytone Biotech begins patient dosing in clinical trial of RTP-008 to treat dry eye disease: Beijing Tuesday, August 5, 2025, 13:00 Hrs [IST] Raytone Biotech, a clinical-stage bio ...
The COA Research and Manufacturing Limited Company (COARMLC) has officially denied claims suggesting that its product, COA-72 ...
A modified version of a diet known to lower blood pressure is also effective at lowering glucose in adults with type 2 diabetes, according to a clinical trial led by researchers at the Johns Hopkins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results